Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, Molecular Devices Disclose Exec Compensation; NIDDK, IO Informatics and Rubicon Name New Advisors; and Others

Luminex has awarded bonuses to officers for 2005.

 

According to documents filed with the Securities and Exchange Commission last week, CEO Patrick Balthrop will receive $400,000; VP of finance Harriss Currie was awarded $128,071; VP of sales Randel Marfin was awarded $127,915; VP of R&D James Jacobson will receive $126,573; VP of manufacturing Oliver Meek will receive $103,898; and David Reiter, general counsel, will receive $125,842.


Molecular Devices also announced cash bonuses for executive officers, as well as annual salaries.

 

According to SEC filings last week, CEO Joseph Keegan will receive $600,000 in bonuses and $445,000 in salary; Steven Davenport, VP of European operations was awarded £62,000 ($108,000) in bonuses and £101,000 in salary; Timothy Harkness, chief financial officer, was awarded $270,000 in bonuses and $334,000  in salary; Jan Hughes, VP of marketing, will receive $138,000 in bonuses and $210,000 in salary; Gillian Humphries, VP of strategic affairs, was awarded $30,000 in bonuses and $100,000 in salary; Robert Murray, VP of operations, will receive $151,000 in bonuses and $227,000 in salary; Thomas O'Lenic, VP North America, will receive $157,000 in bonuses and $223,000 in salary; Patricia Sharp, VP of human resources, was awarded $140,000 in bonuses and $225,000 in salary; and Richard Sportsman, VP R&D will receive $102,000 in bonuses and $193,000 in salary.


The National Institute of Diabetes and Digestive and Kidney Diseases announced five new members to its advisory council yesterday. They are David Klurfeld, Mitchell Lazar, Juanita Lynne Merchant, David Perlmutter, and Margery Deutz Perry.

 

Klurfeld is a national program leader in human nutrition in the agricultural research service at the US Department of Agriculture.

 

Lazar heads the department of endocrinology, diabetes and metabolism at the University of Pennsylvania School of Medicine. He is also the director of the institute for diabetes, obesity and metabolism at the Hospital of the University of Pennsylvania.

 

Merchant is a professor of internal medicine and molecular and integrative physiology at the University of Michigan.

 

Perlmutter is a professor of cell biology and physiology at the University of Pittsburgh School of Medicine. He is also scientific director of the John G. Rangos Sr. Research Center and physician-in-chief at Children's Hospital of Pittsburgh.

 

Perry is the former chair of research at the Juvenile Diabetes Research Foundation International.


IO Informatics announced the formation of a scientific advisory board yesterday. The new advisors are James Golden, Sangtae Kim, Kelvin Lee, Stuart Marson and Robert Stevenson.

 

Golden is chief technology officer of SAIC's life sciences office. He has also held positions at Life Science Insights, 454, CuraGen, GeneSys and Pioneer Hi-Bred.

 

Kim is a professor of mechanical engineering at Purdue University. He has previously held positions at Lilly Research Labs and Parke-Davis.

 

Lee is a professor of molecular and cell biology at Cornell University. He also directs the Cornell Institute for Biotechnology and Life Science Technologies at the New York State Center for Life Science Enterprise.

 

Marson is the founder of several companies, including Molecular Design Limited.

 

Stevenson is the founder of Abacus Group. He has held positions at BioRad, Varian, and Shell Development.


Rubicon Genomics has formed a new scientific advisory board for its cancer molecular diagnostics programs, the company said Monday. Anul Chinnaiyan was the first advisor named.

 

Chinnaiyan is a professor of pathology at the University of Michigan. He is also the co-director of the division of pathology informatics and director of the cancer bioinformatics core.


László Karlinger was named chief financial officer of Budapest, Hungary -based Solvo Biotechnology.

 

Before joining Solvo, Karlinger held positions at Diageo Budapest Business Service Center and KFKI Group. He has a degree from the Budapest University of Economic Sciences.


TGen Foundation named Abe Jacob national director of development for the foundation's neurogenomics division.

 

Jacob spent more than a decade in Asia, primarily working for Nortel Networks as director of commercial marketing for South Asia. He has an MBA from Thunderbird.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.